Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China 2021-12-06 09:16
Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma 2021-12-04 21:00
I-Mab Announces First Two Patients Dosed in U.S. Phase 2 Combination Trial of Uliledlimab with Atezolizumab in Patients with Selected Advanced Solid Tumors 2021-12-03 21:00
OrigiMed announced its strategic partnership with Janssen to develop clinical innovative solutions driven by data science 2021-12-03 17:01
Biotheus' Bifunctional Therapeutic PM8001 has been Approved by the USFDA to Enter Phase II Studies 2021-12-03 16:23
InnoCare Announces Inclusion of Orelabrutinib in China National Reimbursement Drug List 2021-12-03 10:13
Hepagene Therapeutics Initiates the RISE Study, a Phase IIa Clinical Trial of HPG1860 in Patients with NASH 2021-12-02 23:00
MingMed Biotechnology Announces U.S. FDA Approval for IND Application of HPK1 Small Molecule Inhibitor PRJ1-3024, and Completion of Phase I Clinical Trials for Dry AMD Treatment Drug QA102 2021-12-02 22:00
Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics 2021-12-02 21:58
Rayence's Low-Dose Detector "GreenON" Receives Critical Acclaim at RSNA 2021 2021-12-02 21:30
DiNovA Medtech Announces Mr. Yaniv Kirma to Join as DiNovA Israel Incubator's Chief Operating Officer 2021-12-02 16:00
Fifty percent recruitment milestone for PROPELLER prostate cancer trial 2021-12-01 21:57
Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Peripheral T-Cell Lymphoma(PTCL) in Japan 2021-12-01 21:54
U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders 2021-12-01 19:00
Great Bay Bio Completes a Near USD 10M Series A Fundraising 2021-12-01 15:00
Binhai New Area to spearhead China's medical industry development 2021-12-01 11:20
Ascentage Pharma and Innovent Biologics Announce Approval for China's First Third-Generation BCR-ABL TKI Olverembatinib, Marking a Clinical Breakthrough in the Treatment of Chronic Myeloid Leukemia 2021-12-01 08:00
Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease 2021-11-30 21:30
ABM Therapeutics Receives IND Approval in China for BRAF Inhibitor ABM-1310 2021-11-30 13:00
Q-Sera enters exclusive agreement with Terumo Corporation for RAPClot™ rapid serum blood collection tube technology in Japan 2021-11-30 01:00
1 150 151 152 153 154 433